The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer
Dilek Çağlayan, Mehmet Koçak, Çağlayan Geredeli, Ali Murat Tatlı, Sema Sezgin Göksu, Melek Karakurt Eryılmaz, Murat Araz, Mehmet Artaç
Topics & Concepts
ConcomitantPalbociclibInternal medicineMedicineCyclin-dependent kinaseProgression-free survivalGastroenterologyOncologyCancerPharmacologyMetastatic breast cancerChemotherapyBreast cancerCell cycleAdvanced Breast Cancer TherapiesCancer, Lipids, and MetabolismHER2/EGFR in Cancer Research